$MTVA
MetaVia Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$1.59
▲+0.00%+$0.000
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateMetaVia Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is MTVA up today? It is at $1.59 (+0.00%), and our scanner flagged it 10 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment MTVA spikes, and full due diligence on MTVA — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $MTVA 10 times in the last 30 days. Create a free account to track $MTVA, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on MTVA from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for MTVA today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Glickman Mark A Director | Acquired (grant/award) | +17K 0.3% of company | added 100% | 21K | n/a | Jun 8, 26 |
Koven Andrew I Director | Acquired (grant/award) | +17K 0.3% of company | added 100% | 21K | n/a | Jun 8, 26 |
Groves Jason L Director | Acquired (grant/award) | +17K 0.3% of company | added 100% | 21K | n/a | Jun 8, 26 |
Salsbury Michael Director | Acquired (grant/award) | +17K 0.3% of company | added 100% | 21K | n/a | Jun 8, 26 |
Strickland D Gordon Director | Acquired (grant/award) | +17K 0.3% of company | added 100% | 21K | n/a | Jun 8, 26 |
Tursi James Patrick Director | Acquired (grant/award) | +17K 0.3% of company | added 100% | 21K | n/a | Jun 8, 26 |
Kim Hyung Heon Officer | Acquired (grant/award) | +32K 0.5% of company | added 100% | 38K | n/a | Jan 23, 26 |
Woodworth Marshall H Officer | Acquired (grant/award) | +28K 0.4% of company | added 100% | 31K | n/a | Jan 23, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on MTVA from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for MTVA today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
MTVA last traded at $1.59, up 0.00% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
MetaVia Inc. Common Stock (MTVA) is next expected to report earnings on Thursday, November 5, 2026, about 49 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The MTVA Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged MTVA 10 times in the last 30 days.
MTVA (MetaVia Inc. Common Stock) trades on XNAS, with a market cap of about $10M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge MTVA for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$MTVA discussion
Sign in to ask a question or join the discussion.